Narcotic Drugs under International Control (“Yellow List”)
Source: International Narcotics Control Board. Narcotic Drugs under International Control—The Yellow List, 50th Edition, December 2011
Section 1
And the isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
[And] the esters and ethers, unless appearing in another Schedule, of the drugs in this Schedule, whenever the existence of such esters or ethers is possible;
[And] the salts of the drugs listed in this Schedule, including the salts of the esters, ethers and isomers as provided above whenever the existence of such salts is possible.
Acetorphine (3-O-Acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine)
CA: CDSA Schedule I Section 1 Subsection 5 Acetorphine
UK: MDA Part I Class A Section 1(a) Acetorphine
US: CSA Schedule I Section c Subsection 1 Acetorphine
See also Narcotics Part 1 Section 3 Acetorphine
Acetyl-alpha-methylfentanyl (N-[1-(α-Methylphenethyl)-4-piperidyl]acetanilide)
CA: CDSA Schedule I Section 16 Subsection 1 Acetyl-α-methylfentanyl
UK: MDA Part I Class A Section 1(d) Acetyl-α-methylfentanyl
US: CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
See also Narcotics Part 1 Section 3 Acetyl-alpha-methylfentanyl
Acetylmethadol (3-Acetoxy-6-dimethylamino-4,4-diphenylheptane)
CA: CDSA Schedule I Section 6 Subsection 1 Acetylmethadol
UK: MDA Part I Class A Section 1(a) Methadyl acetate
US: CSA Schedule I Section b Subsection 2 Acetylmethadol
Alfentanil (N-[1-[2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide)
CA: CDSA Schedule I Section 16 Subsection 2 Alfentanil
UK: MDA Part I Class A Section 1(a) Alfentanil
US: CSA Schedule II Section c Subsection 1 Alfentanil
Allylprodine (3-Allyl-1-methyl-4-phenyl-4-propionoxypiperidine)
CA: CDSA Schedule I Section 3 Subsection 1 Allylprodine
UK: MDA Part I Class A Section 1(a) Allylprodine
US: CSA Schedule I Section b Subsection 3 Allylprodine
Alphacetylmethadol (α-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane)
CA: CDSA Schedule I Section 6 Subsection 2 Alphacetylmethadol
UK: MDA Part I Class A Section 1(a) Alphacetylmethadol
US: CSA Schedule I Section b Subsection 4 Alphacetylmethadol
Alphameprodine (α-3-Ethyl-1-methyl-4-phenyl-4-propionoxypiperidine)
CA: CDSA Schedule I Section 3 Subsection 2 Alphameprodine
UK: MDA Part I Class A Section 1(a) Alphameprodine
US: CSA Schedule I Section b Subsection 5 Alphameprodine
Alphamethadol (α-6-Dimethylamino-4,4-diphenyl-3-heptanol)
CA: CDSA Schedule I Section 6 Subsection 3 Alphamethadol
UK: MDA Part I Class A Section 1(a) Alphamethadol
US: CSA Schedule I Section b Subsection 6 Alphamethadol
Alpha-Methylfentanyl (N-[1-(α-Methylphenethyl)-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
See also Narcotics Part 1 Section 3 Alpha-Methylfentanyl
Alpha-Methylthiofentanyl (N-[1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
See also Narcotics Part 1 Section 3 Alpha-Methylthiofentanyl
Alphaprodine (α-1,3-Dimethyl-4-phenyl-4-propionoxypiperidine)
CA: CDSA Schedule I Section 3 Subsection 3 Alphaprodine
UK: MDA Part I Class A Section 1(a) Alphaprodine
US: CSA Schedule II Section c Subsection 2 Alphaprodine
Anileridine (1-p-Aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 4 Anileridine
UK: MDA Part I Class A Section 1(a) Anileridine
US: CSA Schedule II Section c Subsection 3 Anileridine
Benzethidine (1-(2-Benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 7 Benzethidine
UK: MDA Part I Class A Section 1(a) Benzethidine
US: CSA Schedule I Section b Subsection 9 Benzethidine
Benzylmorphine (3-Benzylmorphine)
CA: CDSA Schedule I Section 1 Subsection 7 Benzylmorphine
UK: MDA Part I Class A Section 1(a) Benzylmorphine
US: CSA Schedule I Section c Subsection 3 Benzylmorphine
Betacetylmethadol (β-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane)
CA: CDSA Schedule I Section 6 Subsection 4 Betacetylmethadol
UK: MDA Part I Class A Section 1(a) Betacetylmethadol
US: CSA Schedule I Section b Subsection 10 Betacetylmethadol
Beta-Hydroxyfentanyl (N-[1-(β-Hydroxyphenethyl)-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
See also Narcotics Part 1 Section 3 Beta-Hydroxyfentanyl
Beta-Hydroxy-3-methylfentanyl (N-[1-(β-Hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
See also Narcotics Part 1 Section 3 Beta-Hydroxy-3-methylfentanyl
Betameprodine (β-3-Ethyl-1-methyl-4-phenyl-4-propionoxypiperidine)
CA: CDSA Schedule I Section 3 Subsection 5 Betameprodine
UK: MDA Part I Class A Section 1(a) Betameprodine
US: CSA Schedule I Section b Subsection 13 Betameprodine
Betamethadol (β-6-Dimethylamino-4,4-diphenyl-3-heptanol)
CA: CDSA Schedule I Section 6 Subsection 5 Betamethadol
UK: MDA Part I Class A Section 1(a) Betamethadol
US: CSA Schedule I Section b Subsection 14 Betamethadol
Betaprodine (β-1,3-Dimethyl-4-phenyl-4-propionoxypiperidine)
CA: CDSA Schedule I Section 3 Subsection 6 Betaprodine
UK: MDA Part I Class A Section 1(a) Betaprodine
US: CSA Schedule I Section b Subsection 15 Betaprodine
Bezitramide (1-(3-Cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine)
CA: CDSA Schedule I Section 13 Subsection 3 Bezitramide
UK: MDA Part I Class A Section 1(a) Bezitramide
US: CSA Schedule II Section c Subsection 4 Bezitramide
Cannabis (Indian hemp) and Cannabis resin (Resin of Indian hemp) and Extracts and tinctures of cannabis
CA: CDSA Schedule II Section 1 Subsection 2 Cannabis, Schedule VII Section 2 Cannabis and Schedule VIII Section 2 Cannabis
UK: MDA Part II Class B Section 1(a) Cannabis
US: CSA Schedule I Section d Subsection 23 Marihuana
See also Narcotics Part 1 Section 3 Cannabis
CA: CDSA Schedule II Section 1 Subsection 1 Cannabis resin, Schedule VII Section 1 Cannabis resin and Schedule VIII Section 1 Cannabis resin
UK: MDA Part II Class B Section 1(a) Cannabis resin
See also Narcotics Part 1 Section 3 Cannabis resin
US: [proposed] CSA Schedule I Section d Subsection 36 Marihuana extract
Clonitazene (2-(p-Chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole)
CA: CDSA Schedule I Section 13 Subsection 1 Clonitazene
UK: MDA Part I Class A Section 1(a) Clonitazene
US: CSA Schedule I Section b Subsection 16 Clonitazene
Coca leaf
CA: CDSA Schedule I Section 2 Subsection 1 Coca leaves
UK: MDA Part I Class A Section 1(a) Coca leaf
US: CSA Schedule II Section b Subsection 4 Coca leaves
Cocaine (Methyl ester of benzoylecgonine)
For the calculation of estimates and statistics in accordance with the terms of the 1961 Convention, coca leaf preparations containing more than 0.1 per cent of Cocaine and made direct from Coca leaf should be considered to be Coca leaf (preparations).
Codoxime (Dihydrocodeinone-6-carboxymethyloxime)
CA: CDSA Schedule I Section 1 Subsection 8 Codoxime
UK: MDA Part I Class A Section 1(a) Dihydrocodeinone O-carboxymethyloxime
Concentrate of poppy straw (the material arising when poppy straw has entered into a process for the concentration of its alkaloids when such material is made available in trade)
UK: MDA Part I Class A Section 1(a) Concentrate of poppy-straw
US: CSA Schedule II Section b Subsection 5 Concentrate of poppy straw
Desomorphine (Dihydrodeoxymorphine)
CA: CDSA Schedule I Section 1 Subsection 9 Desomorphine
UK: MDA Part I Class A Section 1(a) Desomorphine
US: CSA Schedule I Section c Subsection 7 Desomorphine
See also Narcotics Part 1 Section 3 Desomorphine
Dextromoramide ((+)-4-[2-Methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine)
CA: CDSA Schedule I Section 9 Subsection 1 Dextromoramide
UK: MDA Part I Class A Section 1(a) Dextromoramide
US: CSA Schedule I Section b Subsection 17 Dextromoramide
Diampromide (N-[2-(Methylphenethylamino)propyl]propionanilide)
CA: CDSA Schedule I Section 12 Subsection 1 Diampromide
UK: MDA Part I Class A Section 1(a) Diampromide
US: CSA Schedule I Section b Subsection 18 Diampromide
Diethylthiambutene (3-Diethylamino-1,1-di(2ʹ-thienyl)-1-butene)
CA: CDSA Schedule I Section 8 Subsection 1 Diethylthiambutene
UK: MDA Part I Class A Section 1(a) Diethylthiambutene
US: CSA Schedule I Section b Subsection 19 Diethylthiambutene
Dihydroetorphine (7,8-Dihydro-7α-[1-(R)-hydroxy-1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine)
UK: MDA Part I Class A Section 1(a) Dihydroetorphine
US: CSA Schedule II Section b Subsection 1 Item ii Dihydroetorphine
Dihydromorphine
CA: CDSA Schedule I Section 1 Subsection 12 Dihydromorphine
UK: MDA Part I Class A Section 1(a) Dihydromorphine
US: CSA Schedule I Section c Subsection 8 Dihydromorphine
Dimenoxadol (2-Dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate)
CA: CDSA Schedule I Section 7 Subsection 1 Dimenoxadol
UK: MDA Part I Class A Section 1(a) Dimenoxadole
US: CSA Schedule I Section b Subsection 21 Dimenoxadol
Dimepheptanol (6-Dimethylamino-4,4-diphenyl-3-heptanol)
CA: CDSA Schedule I Section 6 Subsection 6 Dimepheptanol
UK: MDA Part I Class A Section 1(a) Dimepheptanol
US: CSA Schedule I Section b Subsection 22 Dimepheptanol
Dimethylthiambutene (3-Dimethylamino-1,1-di(2ʹ-thienyl)-1-butene)
CA: CDSA Schedule I Section 8 Subsection 2 Dimethylthiambutene
UK: MDA Part I Class A Section 1(a) Dimethylthiambutene
US: CSA Schedule I Section b Subsection 23 Dimethylthiambutene
Dioxaphetyl butyrate (Ethyl-4-morpholino-2,2-diphenylbutyrate)
CA: CDSA Schedule I Section 7 Subsection 2 Dioxaphetyl butyrate
UK: MDA Part I Class A Section 1(a) Dioxaphetyl butyrate
US: CSA Schedule I Section b Subsection 24 Dioxaphetyl butyrate
Diphenoxylate (1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 8 Diphenoxylate
UK: MDA Part I Class A Section 1(a) Diphenoxylate
US: CSA Schedule II Section c Subsection 8 Diphenoxylate and Schedule V Section c Subsection 4 Diphenoxylate
See also Narcotics Part 2 Section 6 Diphenoxylate
Dipipanone (4,4-Diphenyl-6-piperidine-3-heptanone)
CA: CDSA Schedule I Section 5 Subsection 2 Dipipanone
UK: MDA Part I Class A Section 1(a) Dipipanone
US: CSA Schedule I Section b Subsection 25 Dipipanone
Drotebanol (3,4-Dimethoxy-17-methylmorphinan-6β,14-diol)
CA: CDSA Schedule I Section 10 Subsection 2 Drotebanol
UK: MDA Part I Class A Section 1(a) Drotebanol
US: CSA Schedule I Section c Subsection 9 Drotebanol
Ethylmethylthiambutene (3-Ethylmethylamino-1,1-di(2ʹ-thienyl)-1-butene)
CA: CDSA Schedule I Section 8 Subsection 3 Ethylmethylthiambutene
UK: MDA Part I Class A Section 1(a) Ethylmethylthiambutene
US: CSA Schedule I Section b Subsection 26 Ethylmethylthiambutene
Etonitazene (1-Diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole)
CA: CDSA Schedule I Section 13 Subsection 2 Etonitazene
UK: MDA Part I Class A Section 1(a) Etonitazene
US: CSA Schedule I Section b Subsection 27 Etonitazene
Etoxeridine (1-[2-(2-Hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 10 Etoxeridine
UK: MDA Part I Class A Section 1(a) Etoxeridine
US: CSA Schedule I Section b Subsection 28 Etoxeridine
Furethidine (1-(2-Tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 11 Furethidine
UK: MDA Part I Class A Section 1(a) Furethidine
US: CSA Schedule I Section b Subsection 29 Furethidine
Heroin (Diacetylmorphine)
CA: CDSA Schedule I Section 1 Subsection 10 Diacetylmorphine
UK: MDA Part I Class A Section 1(a) Diamorphine
US: CSA Schedule I Section c Subsection 11 Heroin
See also Narcotics Part 1 Section 3 Heroin
Hydrocodone (Dihydrocodeinone)
CA: CDSA Schedule I Section 1 Subsection 15 Hydrocodone
UK: MDA Part I Class A Section 1(a) Hydrocodone
US: CSA Schedule II Section b Subsection 1 Item vi Hydrocodone
US: [revoked] CSA Schedule III Section e Subsection 1 Dihydrocodeinone and Dihydrocodeinone
⇒
PubChem: 5284569; ChemSpider: 4447623; Drugs Forum: Hydrocodone; Erowid: Hydrocodone; Wikipedia: Hydrocodone
Hydromorphinol (14-Hydroxydihydromorphine)
CA: CDSA Schedule I Section 1 Subsection 16 Hydromorphinol
UK: MDA Part I Class A Section 1(a) Hydromorphinol
US: CSA Schedule I Section c Subsection 12 Hydromorphinol
Hydromorphone (Dihydromorphinone)
CA: CDSA Schedule I Section 1 Subsection 17 Hydromorphone
UK: MDA Part I Class A Section 1(a) Hydromorphone
US: CSA Schedule II Section b Subsection 1 Item vii Hydromorphone
⇒
PubChem: 5284570; ChemSpider: 4447624; Drugs Forum: Hydromorphone; Erowid: Hydromorphone; Wikipedia: Hydromorphone
Hydroxypethidine (4-m-Hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 12 Hydroxypethidine
UK: [revoked] MDA Part I Class A Section 1(a) Hydroxypethidine
US: CSA Schedule I Section b Subsection 30 Hydroxypethidine
Isomethadone (6-Dimethylamino-5-methyl-4,4-diphenyl-3-hexanone)
CA: CDSA Schedule I Section 5 Subsection 3 Isomethadone
UK: MDA Part I Class A Section 1(a) Isomethadone
US: CSA Schedule II Section c Subsection 10 Isomethadone
Ketobemidone (4-m-Hydroxyphenyl-1-methyl-4-propionylpiperidine)
CA: CDSA Schedule I Section 3 Subsection 13 Ketobemidone
UK: MDA Part I Class A Section 1(a) Ketobemidone
US: CSA Schedule I Section b Subsection 31 Ketobemidone
See also Narcotics Part 1 Section 3 Ketobemidone
Levomethorphan ((–)-3-Methoxy-N-methylmorphinan)
CA: CDSA Schedule I Section 10 Subsection 3 Levomethorphan
UK: MDA Part I Class A Section 1(a) Levomethorphan
US: CSA Schedule II Section c Subsection 12 Levomethorphan
⇒
PubChem: 5362449; ChemSpider: 4642423; Bluelight: Levomethorphan; Drugs Forum: Levomethorphan; Wikipedia: Levomethorphan
Levomoramide ((–)-4-[2-Methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine)
CA: CDSA Schedule I Section 9 Subsection 3 Levomoramide
UK: MDA Part I Class A Section 1(a) Levomoramide
US: CSA Schedule I Section b Subsection 32 Levomoramide
Levophenacylmorphan ((–)-3-Hydroxy-N-phenacylmorphinan)
CA: CDSA Schedule I Section 10 Subsection 5 Levophenacylmorphan
UK: MDA Part I Class A Section 1(a) Levophenacylmorphan
US: CSA Schedule I Section b Subsection 33 Levophenacylmorphan
Levorphanol ((–)-3-Hydroxy-N-methylmorphinan)
CA: CDSA Schedule I Section 10 Subsection 4 Levorphanol
UK: MDA Part I Class A Section 1(a) Levorphanol
US: CSA Schedule II Section c Subsection 13 Levorphanol
⇒
PubChem: 5359272; ChemSpider: 16736212; Bluelight: Levorphanol ; Drugs Forum: Levorphanol ; Erowid: Levorphanol Synthesis; Wikipedia: Levorphanol
Metazocine (2ʹ-Hydroxy-2,5,9-trimethyl-6,7-benzomorphan)
CA: CDSA Schedule I Section 11 Subsection 2 Metazocine
UK: MDA Part I Class A Section 1(a) Metazocine and Part II Class B Section 1(a) Metazocine
US: CSA Schedule II Section c Subsection 14 Metazocine
See also Psychotropics Schedule III Metazocine
Methadone intermediate (4-Cyano-2-dimethylamino-4,4-diphenylbutane)
CA: CDSA Schedule I Section 5 Subsection 1 Dimethylaminodiphenylbutanonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-2-dimethylamino-4,4-diphenylbutane
US: CSA Schedule II Section c Subsection 16 Methadone-intermediate
Methyldesorphine (6-Methyl-Δ6-deoxymorphine)
CA: CDSA Schedule I Section 1 Subsection 18 Methyldesorphine
UK: MDA Part I Class A Section 1(a) Methyldesorphine
US: CSA Schedule I Section c Subsection 13 Methyldesorphine
Methyldihydromorphine (6-Methyldihydromorphine)
CA: CDSA Schedule I Section 1 Subsection 19 Methyldihydromorphine
UK: MDA Part I Class A Section 1(a) Methyldihydromorphine
US: CSA Schedule I Section c Subsection 14 Methyldihydromorphine
3-Methylfentanyl (N-(3-Methyl-1-phenethyl-4-piperidyl)propionanilide)
CA: CDSA Schedule I Section 16 Subsection 10 3-Methylfentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylfentanyl
US: CSA Schedule I Section b Subsection 34 3-Methylfentanyl
See also Narcotics Part 1 Section 3 3-Methylfentanyl
3-Methylthiofentanyl (N-(3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl)propionanilide)
CA: CDSA Schedule I Section 16 Subsection 11 3-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 35 3-Methylthiofentanyl
See also Narcotics Part 1 Section 3 3-Methylthiofentanyl
Moramide intermediate (2-Methyl-3-morpholino-1,1-diphenylpropane carboxylic acid)
CA: CDSA Schedule I Section 9 Subsection 2 Diphenylmorpholinoisovaleric acid
UK: MDA Part I Class A Section 1(a) 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
Morpheridine (1-(2-Morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 15 Morpheridine
UK: MDA Part I Class A Section 1(a) Morpheridine
US: CSA Schedule I Section b Subsection 36 Morpheridine
Morphine methobromide
Morphine-N-oxide
Codeine-N-oxide
Morphine methobromide and Morphine-N-oxide and other pentavalent nitrogen morphine derivatives including in particular the Morphine-N-oxide derivatives, one of which is Codeine-N-oxide
UK: MDA Part I Class A Section 1(a) Morphine methobromide
US: CSA Schedule I Section c Subsection 15 Morphine methobromide
CA: CDSA Schedule I Section 1 Subsection 21 Morphine-N-oxide
UK: MDA Part I Class A Section 1(a) Morphine N-oxide
US: CSA Schedule I Section c Subsection 17 Morphine-N-oxide
US: CSA Schedule I Section c Subsection 5 Codeine-N-oxide
Nicomorphine (3,6-Dinicotinylmorphine)
CA: CDSA Schedule I Section 1 Subsection 25 Nicomorphine
UK: MDA Part I Class A Section 1(a) Nicomorphine
US: CSA Schedule I Section c Subsection 20 Nicomorphine
Noracymethadol ((±)-α-3-Acetoxy-6-methylamino-4,4-diphenylheptane)
CA: CDSA Schedule I Section 6 Subsection 7 Noracymethadol
UK: MDA Part I Class A Section 1(a) Noracymethadol
US: CSA Schedule I Section b Subsection 38 Noracymethadol
Norlevorphanol ((–)-3-Hydroxymorphinan)
CA: CDSA Schedule I Section 10 Subsection 6 Norlevorphanol
UK: MDA Part I Class A Section 1(a) Norlevorphanol
US: CSA Schedule I Section b Subsection 39 Norlevorphanol
Normethadone (6-Dimethylamino-4,4-diphenyl-3-hexanone)
CA: CDSA Schedule I Section 5 Subsection 5 Normethadone
UK: MDA Part I Class A Section 1(a) Normethadone
US: CSA Schedule I Section b Subsection 40 Normethadone
Normorphine (Demethylmorphine)
CA: CDSA Schedule I Section 1 Subsection 27 Normorphine
UK: MDA Part I Class A Section 1(a) Normorphine
US: CSA Schedule I Section c Subsection 21 Normorphine
Norpipanone (4,4-Diphenyl-6-piperidino-3-hexanone)
CA: CDSA Schedule I Section 5 Subsection 6 Norpipanone
UK: MDA Part I Class A Section 1(a) Norpipanone
US: CSA Schedule I Section b Subsection 41 Norpipanone
Opium
[A]ll preparations made direct from opium are considered to be opium (preparations). If the preparations are not made direct from opium itself but are obtained by a mixture of opium alkaloids (as in the case, for example, with pantopon, omnopon and papaveretum) and should be considered as Morphine (preparations).
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: Opium
Oxymorphone (14-Hydroxydihydromorphinone)
CA: CDSA Schedule I Section 1 Subsection 29 Oxymorphone
UK: MDA Part I Class A Section 1(a) Oxymorphone
US: CSA Schedule II Section b Subsection 1 Item xiv Oxymorphone
⇒
PubChem: 5284604; ChemSpider: 4447650; Bluelight: Oxymorphone; Drugs Forum: Oxymorphone; Erowid: Oxymorphone; Wikipedia: Oxymorphone
Para-Fluorofentanyl (4ʹ-Fluoro-N-(1-phenethyl-4-piperidyl)propionanilide)
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
See also Narcotics Part 1 Section 3 Para-Fluorofentanyl
Pethidine intermediate A (4-Cyano-1-methyl-4-phenylpiperidine)
CA: CDSA Schedule I Section 3 Subsection 14 Methylphenylisonipecotonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-1-methyl-4-phenylpiperidine
US: CSA Schedule II Section c Subsection 19 Pethidine-intermediate-A
Pethidine intermediate B (4-Phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 16 Norpethidine
UK: MDA Part I Class A Section 1(a) 4-Phenylpiperidine-4-carboxylic acid ethyl ester
US: CSA Schedule II Section c Subsection 20 Pethidine-intermediate-B
Pethidine intermediate C (1-Methyl-4-phenylpiperidine-4-carboxylic acid)
CA: CDSA Schedule I Section 3 Subsection 22 Pethidine intermediate C
UK: MDA Part I Class A Section 1(a) 1-Methyl-4-phenylpiperidine-4-carboxylic acid
US: CSA Schedule II Section c Subsection 21 Pethidine-intermediate-C
Phenadoxone (6-Morpholino-4,4-diphenyl-3-heptanone)
CA: CDSA Schedule I Section 5 Subsection 7 Phenadoxone
UK: MDA Part I Class A Section 1(a) Phenadoxone
US: CSA Schedule I Section b Subsection 44 Phenadoxone
Phenampromide (N-(1-Methyl-2-piperidinoethyl)propionanilide)
CA: CDSA Schedule I Section 12 Subsection 2 Phenampromide
UK: MDA Part I Class A Section 1(a) Phenampromide
US: CSA Schedule I Section b Subsection 45 Phenampromide
Phenazocine (2ʹ-Hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan)
CA: CDSA Schedule I Section 11 Subsection 1 Phenazocine
UK: MDA Part I Class A Section 1(a) Phenazocine
US: CSA Schedule II Section c Subsection 22 Phenazocine
Phenomorphan (3-Hydroxy-N-phenethylmorphinan)
CA: CDSA Schedule I Section 10 Subsection 7 Phenomorphan
UK: MDA Part I Class A Section 1(a) Phenomorphan
US: CSA Schedule I Section b Subsection 46 Phenomorphan
Phenoperidine (1-(3-Hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 18 Phenoperidine
UK: MDA Part I Class A Section 1(a) Phenoperidine
US: CSA Schedule I Section b Subsection 47 Phenoperidine
Piminodine (4-Phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester)
CA: CDSA Schedule I Section 3 Subsection 19 Piminodine
UK: MDA Part I Class A Section 1(a) Piminodine
US: CSA Schedule II Section c Subsection 23 Piminodine
Piritramide (1-(3-Cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide)
CA: CDSA Schedule I Section 15 Piritramide
UK: MDA Part I Class A Section 1(a) Piritramide
US: CSA Schedule I Section b Subsection 48 Piritramide
Proheptazine (1,3-Dimethyl-4-phenyl-4-propionoxyazacycloheptane)
CA: CDSA Schedule I Section 4 Subsection 1 Proheptazine
UK: MDA Part I Class A Section 1(a) Proheptazine
US: CSA Schedule I Section b Subsection 49 Proheptazine
Properidine (1-Methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester)
CA: CDSA Schedule I Section 3 Subsection 20 Properidine
UK: MDA Part I Class A Section 1(a) Properidine
US: CSA Schedule I Section b Subsection 50 Properidine
Racemethorphan ((±)-3-Methoxy-N-methylmorphinan)
CA: CDSA Schedule I Section 10 Subsection 8 Racemethorphan
UK: MDA Part I Class A Section 1(a) Racemethorphan
US: CSA Schedule II Section c Subsection 24 Racemethorphan
Racemoramide ((±)-4-[2-Methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine)
CA: CDSA Schedule I Section 9 Subsection 4 Racemoramide
UK: MDA Part I Class A Section 1(a) Racemoramide
US: CSA Schedule I Section b Subsection 52 Racemoramide
Racemorphan ((±)-3-Hydroxy-N-methylmorphinan)
CA: CDSA Schedule I Section 10 Subsection 9 Racemorphan
UK: MDA Part I Class A Section 1(a) Racemorphan
US: CSA Schedule II Section c Subsection 25 Racemorphan
Remifentanil (1-(2-Methoxy carbonylethyl)-4-(phenylpropionylamino)piperidine-4-carboxylic acid methyl ester)
CA: CDSA Schedule I Section 16 Subsection 11.1 Remifentanil
UK: MDA Part I Class A Section 1(a) Remifentanil
US: CSA Schedule II Section c Subsection 26 Remifentanil
Sufentanil (N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 12 Sufentanil
UK: MDA Part I Class A Section 1(a) Sufentanil
US: CSA Schedule II Section c Subsection 27 Sufentanil
⇒
PubChem: 41693; ChemSpider: 38043; Bluelight: Sufentanil; Erowid: Sufentanil total synthesis; Wikipedia: Sufentanil
Thiofentanyl (N-[1-[2-(Thienyl)ethyl]-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 13 Thiofentanyl
UK: MDA Part I Class A Section 1(d) Thiofentanyl
US: CSA Schedule I Section b Subsection 53 Thiofentanyl
See also Narcotics Part 1 Section 3 Thiofentanyl
Trimeperidine (1,2,5-Trimethyl-4-phenyl-4-propionoxypiperidine)
CA: CDSA Schedule I Section 3 Subsection 21 Trimeperidine
UK: MDA Part I Class A Section 1(a) Trimeperidine
US: CSA Schedule I Section b Subsection 55 Trimeperidine
Section 2
And the isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
[And] the salts of the drugs listed in this Schedule, including the salts of the isomers as provided above whenever the existence of such salts is possible.
Acetyldihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 6 Acetyldihydrocodeine
UK: MDA Part II Class B Section 1(a) Acetyldihydrocodeine
US: CSA Schedule I Section c Subsection 2 Acetyldihydrocodeine
See also Narcotics Part 2 Section 1 Acetyldihydrocodeine
Dextropropoxyphene (α-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate)
CA: CDSA Schedule I Section 7 Subsection 3 Dextropropoxyphene
UK: MDA Part III Class C Section 1(a) Dextropropoxyphene
US: CSA Schedule II Section c Subsection 5 Dextropropoxyphene and Schedule IV Section b Subsection 2 Dextropropoxyphene
See also Narcotics Part 2 Section 3 Dextropropoxyphene
Dihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 11 Dihydrocodeine
UK: MDA Part II Class B Section 1(a) Dihydrocodeine
US: CSA Schedule II Section c Subsection 7 Dihydrocodeine, Schedule III Section e Subsection 1 Item iii Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
See also Narcotics Part 2 Section 1 Dihydrocodeine
Ethylmorphine (3-Ethylmorphine)
CA: CDSA Schedule I Section 1 Subsection 13 Ethylmorphine
UK: MDA Part II Class B Section 1(a) Ethylmorphine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
See also Narcotics Part 2 Section 1 Ethylmorphine
Nicocodine (6-Nicotinylcodeine)
CA: CDSA Schedule I Section 1 Subsection 24 Nicocodine
UK: MDA Part II Class B Section 1(a) Nicocodine
US: CSA Schedule I Section c Subsection 19 Nicocodeine
See also Narcotics Part 2 Section 1 Nicocodine
Nicodicodine (6-Nicotinyldihydrocodeine)
Norcodeine (N-Demethylcodeine)
CA: CDSA Schedule I Section 1 Subsection 26 Norcodeine
UK: MDA Part II Class B Section 1(a) Norcodeine
See also Narcotics Part 2 Section 1 Norcodeine
Pholcodine (Morpholinylethylmorphine)
CA: CDSA Schedule I Section 1 Subsection 30 Pholcodine
UK: MDA Part II Class B Section 1(a) Pholcodine
US: CSA Schedule I Section c Subsection 22 Pholcodine
See also Narcotics Part 2 Section 1 Pholcodine
⇒
PubChem: 5311356; ChemSpider: 4470854; Bluelight: Pholcodine; Drugs Forum: Pholcodine; Wikipedia: Pholcodine
Acetorphine (3-O-Acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine)
CA: CDSA Schedule I Section 1 Subsection 5 Acetorphine
UK: MDA Part I Class A Section 1(a) Acetorphine
US: CSA Schedule I Section c Subsection 1 Acetorphine
See also Narcotics Part 1 Section 1 Acetorphine
Acetyl-alpha-methylfentanyl (N-[1-(α-Methylphenethyl)-4-piperidyl]acetanilide)
CA: CDSA Schedule I Section 16 Subsection 1 Acetyl-α-methylfentanyl
UK: MDA Part I Class A Section 1(d) Acetyl-α-methylfentanyl
US: CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
See also Narcotics Part 1 Section 1 Acetyl-alpha-methylfentanyl
Alpha-Methylfentanyl (N-[1-(α-Methylphenethyl)-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
See also Narcotics Part 1 Section 1 Alpha-Methylfentanyl
Alpha-Methylthiofentanyl (N-[1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
See also Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl
Beta-Hydroxy-3-methylfentanyl (N-[1-(β-Hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
See also Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl
Beta-Hydroxyfentanyl (N-[1-(β-Hydroxyphenethyl)-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
See also Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl
Cannabis resin (Resin of Indian hemp)
CA: CDSA Schedule II Section 1 Subsection 1 Cannabis resin, Schedule VII Section 1 Cannabis resin and Schedule VIII Section 1 Cannabis resin
UK: MDA Part II Class B Section 1(a) Cannabis resin
See also Narcotics Part 1 Section 1 Cannabis resin
Desomorphine (Dihydrodeoxymorphine)
CA: CDSA Schedule I Section 1 Subsection 9 Desomorphine
UK: MDA Part I Class A Section 1(a) Desomorphine
US: CSA Schedule I Section c Subsection 7 Desomorphine
See also Narcotics Part 1 Section 1 Desomorphine
Heroin (Diacetylmorphine)
CA: CDSA Schedule I Section 1 Subsection 10 Diacetylmorphine
UK: MDA Part I Class A Section 1(a) Diamorphine
US: CSA Schedule I Section c Subsection 11 Heroin
See also Narcotics Part 1 Section 1 Heroin
Ketobemidone (4-m-Hydroxyphenyl-1-methyl-4-propionylpiperidine)
CA: CDSA Schedule I Section 3 Subsection 13 Ketobemidone
UK: MDA Part I Class A Section 1(a) Ketobemidone
US: CSA Schedule I Section b Subsection 31 Ketobemidone
See also Narcotics Part 1 Section 1 Ketobemidone
3-Methylfentanyl (N-(3-Methyl-1-phenethyl-4-piperidyl)propionanilide)
CA: CDSA Schedule I Section 16 Subsection 10 3-Methylfentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylfentanyl
US: CSA Schedule I Section b Subsection 34 3-Methylfentanyl
See also Narcotics Part 1 Section 1 3-Methylfentanyl
3-Methylthiofentanyl (N-(3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl)propionanilide)
CA: CDSA Schedule I Section 16 Subsection 11 3-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 35 3-Methylthiofentanyl
See also Narcotics Part 1 Section 1 3-Methylthiofentanyl
Para-Fluorofentanyl (4ʹ-Fluoro-N-(1-phenethyl-4-piperidyl)propionanilide)
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
See also Narcotics Part 1 Section 1 Para-Fluorofentanyl
Thiofentanyl (N-[1-[2-(Thienyl)ethyl]-4-piperidyl]propionanilide)
CA: CDSA Schedule I Section 16 Subsection 13 Thiofentanyl
UK: MDA Part I Class A Section 1(d) Thiofentanyl
US: CSA Schedule I Section b Subsection 53 Thiofentanyl
See also Narcotics Part 1 Section 1 Thiofentanyl
Acetyldihydrocodeine
Codeine
Dihydrocodeine
Ethylmorphine
Nicocodine
Nicodicodine
Norcodeine
Pholcodine
1.
Preparations of
- Acetyldihydrocodeine,
- Codeine,
- Dihydrocodeine,
- Ethylmorphine,
- Nicocodine,
- Nicodicodine,
- Norcodeine and
- Pholcodine
CA: CDSA Schedule I Section 1 Subsection 6 Acetyldihydrocodeine
UK: MDA Part II Class B Section 1(a) Acetyldihydrocodeine
US: CSA Schedule I Section c Subsection 2 Acetyldihydrocodeine
See also Narcotics Part 1 Section 2 Acetyldihydrocodeine
See also Narcotics Part 1 Section 2 Codeine
CA: CDSA Schedule I Section 1 Subsection 11 Dihydrocodeine
UK: MDA Part II Class B Section 1(a) Dihydrocodeine
US: CSA Schedule II Section c Subsection 7 Dihydrocodeine, Schedule III Section e Subsection 1 Item iii Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
See also Narcotics Part 1 Section 2 Dihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 13 Ethylmorphine
UK: MDA Part II Class B Section 1(a) Ethylmorphine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
See also Narcotics Part 1 Section 2 Ethylmorphine
CA: CDSA Schedule I Section 1 Subsection 24 Nicocodine
UK: MDA Part II Class B Section 1(a) Nicocodine
US: CSA Schedule I Section c Subsection 19 Nicocodeine
See also Narcotics Part 1 Section 2 Nicocodine
UK: MDA Part II Class B Section 1(a) Nicodicodine
See also Narcotics Part 1 Section 2 Nicodicodine
CA: CDSA Schedule I Section 1 Subsection 26 Norcodeine
UK: MDA Part II Class B Section 1(a) Norcodeine
See also Narcotics Part 1 Section 2 Norcodeine
CA: CDSA Schedule I Section 1 Subsection 30 Pholcodine
UK: MDA Part II Class B Section 1(a) Pholcodine
US: CSA Schedule I Section c Subsection 22 Pholcodine
See also Narcotics Part 1 Section 2 Pholcodine
⇒
PubChem: 5311356; ChemSpider: 4470854; Bluelight: Pholcodine; Drugs Forum: Pholcodine; Wikipedia: Pholcodine
3.
Preparations of Dextropropoxyphene for oral use containing not more than 135 milligrams of Dextropropoxyphene base per dosage unit or with a concentrations of not more than 2.5 per cent in undivided preparations provided that such preparations do not contain any substance controlled under the 1971 Convention of Psychotropic Substances.
CA: CDSA Schedule I Section 7 Subsection 3 Dextropropoxyphene
UK: MDA Part III Class C Section 1(a) Dextropropoxyphene
US: CSA Schedule II Section c Subsection 5 Dextropropoxyphene and Schedule IV Section b Subsection 2 Dextropropoxyphene
See also Narcotics Part 1 Section 2 Dextropropoxyphene
4.
Preparations of Cocaine containing not more than 0.1 per cent of Cocaine calculated as Cocaine base; and
Preparations of Opium or Morphine containing nor more than 0.2 per cent of Morphine calculated as anhydrous Morphine base and compounded with one or more other ingredients and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health.
Preparations of Opium or Morphine containing nor more than 0.2 per cent of Morphine calculated as anhydrous Morphine base and compounded with one or more other ingredients and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health.
CA: CDSA Schedule I Section 2 Subsection 2 Cocaine
UK: MDA Part I Class A Section 1(a) Cocaine
US: CSA Schedule II Section b Subsection 4 Cocaine
See also Narcotics Part 1 Section 1 Cocaine
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: OpiumSee also Narcotics Part 1 Section 1 Morphine
5.
Preparations of Difenoxin containing, per dosage unit, not more than 0.5 milligram of Difenoxin and a quantity of Atropine sulfate equivalent to at least 5 per cent of the dose of Difenoxin.
See also Narcotics Part 1 Section 1 Difenoxin
US: CSA Schedule IV Section b Subsection 1 Atropine sulfate, Schedule V Section c Subsection 4 Atropine sulfate and Subsection 6 Atropine sulfate
See also Narcotics Part 2 Section 6 Atropine sulfate
6.
Preparations of Diphenoxylate containing, per dosage unit, not more than 2.5 milligrams of Diphenoxylate calculated as base and a quantity of Atropine sulfate equivalent to at least 1 per cent of the dose of Diphenoxylate.
CA: CDSA Schedule I Section 3 Subsection 8 Diphenoxylate
UK: MDA Part I Class A Section 1(a) Diphenoxylate
US: CSA Schedule II Section c Subsection 8 Diphenoxylate and Schedule V Section c Subsection 4 Diphenoxylate
See also Narcotics Part 1 Section 1 Diphenoxylate
US: CSA Schedule IV Section b Subsection 1 Atropine sulfate, Schedule V Section c Subsection 4 Atropine sulfate and Subsection 6 Atropine sulfate
See also Narcotics Part 2 Section 5 Atropine sulfate
7.
Preparations of Pulvis ipecacuanhae et opii compositus
- 10 per cent Opium in powder
- 10 per cent ipecacuanha root, in powder well mixed with
- 80 per cent of any other powdered ingredient containing no drug.
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: OpiumPsychotropic Substances under International Control (“Green List”)
Source: International Narcotics Control Board. Psychotropic Substances under International Control—The Green List, 25th Edition, Jan 2014
Brolamfetamine (DOB) ((±)-4-Bromo-2,5-dimethoxy-α-methylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
DET (3-[2-(Diethylamino)ethyl]indole)
CA: CDSA Schedule III Section 6 N,N-Diethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
US: CSA Schedule I Section d Subsection 18 Diethyltryptamine
DMA ((±)-2,5-Dimethoxy-α-methylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
DMHP (3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol)
CA: CDSA Schedule II Section 2 Subsection 1 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
DMT (3-[2-(Dimethylamino)ethyl]indole)
CA: CDSA Schedule III Section 7 N,N-Dimethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
US: CSA Schedule I Section d Subsection 19 Dimethyltryptamine
DOET ((±)-4-Ethyl-2,5-dimethoxy-α-methylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
Eticyclidine (PCE) (N-Ethyl-1-phenylcyclohexylamine)
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
Etryptamine (3-(2-Aminobutyl)indole)
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
N-Hydroxy MDA ((±)-N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
(+)-Lysergide (LSD) (LSD-25) (9,10-Didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide)
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
MDE (N-Ethyl MDA) ((±)-N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine)
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
MDMA ((±)-N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine)
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
Methcathinone (2-(Methylamino)-1-phenylpropan-1-one)
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
4-Methylaminorex ((±)-cis-2-Amino-4-methyl-5-phenyl-2-oxazoline)
CA: CDSA Schedule III Section 18 4-Methylaminorex
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
US: CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
MMDA (5-Methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine)
CA: CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 11 5-Methoxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
US: CSA Schedule I Section d Subsection 8 5-Methoxy-3,4-methylenedioxyamphetamine
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
4-MTA (α-Methyl-4-methylthiophenethylamine)
UK: MDA Part I Class A Section 1(ba) α-Methyl-4-(methylthio)phenethylamine
PMA (p-Methoxy-α-methylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
Psilocybine (3-[2-(Dimethylamino)ethyl]indol-4-yl dihydrogen phosphate)
CA: CDSA Schedule III Section 12 Psilocybin
UK: MDA Part I Class A Section 1(b) Psilocybin
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
Rolicyclidine (PHP) (PCPY) (1-(1-Phenylcyclohexyl)pyrrolidine)
CA: CDSA Schedule III Section 16 Rolicyclidine
UK: MDA Part I Class A Section 1(a) Rolicyclidine
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
STP (DOM) (2,5-Dimethoxy-α,4-dimethylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
Tenamfetamine (MDA) (α-Methyl-3,4-(methylenedioxy)phenethylamine)
CA: CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
CA: [revoked] CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
Tenocyclidine (TCP) (1-[1-(2-Thienyl)cyclohexyl]piperidine)
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine![3D rendering of 7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of 7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
Δ6a(10a) Tetrahydrocannabinol
US: CSA Schedule I Section d Subsection 31 Δ3,4 cis or trans Tetrahydrocannabinol
![3D rendering of (9R,10aR)-8,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of (9R,10aR)-8,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
![3D rendering of (6aR,9R,10aR)-6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of (6aR,9R,10aR)-6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
![3D rendering of (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
(6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
Δ8 Tetrahydrocannabinol
US: CSA Schedule I Section d Subsection 31 Δ6 cis or trans Tetrahydrocannabinol
![3D rendering of 6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of 6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
![3D rendering of (6aR,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAQkAAACgCAIAAACQbg6hAAAACXBIWXMAAC4jAAAuIwF4pT92AAAAHXRFWHRTb2Z0d2FyZQBHUEwgR2hvc3RzY3JpcHQgOC42MG0jaeMAAAnlSURBVHic7d2/jptKGwbw15/OBWROlyoRlnIDWNobIJfgW8BXEMElwCWAlC6VqVKlMFKSMpJRiu0igZQ020TQp5mvmHyIz7y2WRiYsfz8dIo9uxsMa575g2HelZSSAKDnP6Z3AMBSyAYAD9kA4CEbADxkA4CHbADwkA0AHrIBwEM2AHjIBgAP2QDgIRsAPGQDgIdsAPCQDQAesgHAQzYAeMgGAA/ZAOAhGwA867IRx3HTNOrroiiyLDO7P3C3rMtGGIZFUaivsyxL09Ts/sDdsi4bAJZANgB4yAYAD9kA4CEbADxkA4CHbADwkA0AHrIBwEM2AHjIBgAP2QDgIRsAPGQDgIdsAPCQDQAesgHAQzYAeMgGAA/ZAOAhGwA8ZAOA94/pHWDkeZ6mqRDC9I7AXbOr32iaxnVdtXybSojjOO1SbgBLsigbYRiu1+umafb7/eFwKMsyCIIsyzabDVZwAwOkBfb7veM4QoggCOq67v6ormvf94nI87zD4WBqD+EOGc5GWZae5xHRdrsty/Lcrx2PR/Vrvu9f+DUAjYxlo67rIAiIyHXdgR1Ct3uZe/cAzGQjSRIhhBAiiqJn/UOVKCGE4zj7/X6m3QOQy2fjcDi4rktE/anFcGVZtpOQ4/Godw8BlOWy0T2htcwZDodDOwkZHTOAc5bIxqwDoSRJbJmE1LX0fSmEJJJCSN+XbWL71wPtuEIIF8z+Di0wgbZiElLXUggZBFJ1iWUpg0AK8TceyMYNmvEdWvjCq+FJiO/LfviDQPq+lMjGTZrrHdrv98+6PqtLO9dfugMRQvbzX5ZSCCmRjZu0klLO8XF7GIZ5nh+Pxzk2ftVms/E8L4qi5V5ytSL2L6m+v1oxP5rnLw+6zHg/lcEbaQ28tBBUVaffrCpq90TK//sPrGfRvYa3bbul/g2RaUrbrYm9AQ1sfH7jJkURrddERL5PjkNVRWlKaUplaXrPYCT0G5oIQWVJTUObDa1WtNlQ01BZEp7QulnoN/QRgpKEkoT5UX+CgSmH9dBvaBaG4du3b03vBWiAbADwkA0AHrIBwEM2AHjIBgAP2QDgIRsAPGQDgIdsAPCQDQAesgHAQzYAeMgGAA/ZAOAhGwA8ZAOAN2M2iqLI83y+7Z+T5/n379+/fv26fDG0qqo+fvz4+PhYFMXCLw36zbTuVV3X2+2WrhWd0autdON53osXL0bUMBitLSfy+vXrh4cHwgrWt2/e1fUOh4PjODStosAQ/Uo3I2rfjNYvJzK6wAjYY4mVJ6MoUidKkiQLb39gzbTRLtQ5aMPpOA4qFd6ihVZlnamk5cBKN3N0X90j6i5NfbJMdVmWamypq+oILGbRFYu7K6tPPEdHnHNtHYLp3deFkgbs97VUq4KFGVjNe2JFjiljlXON/XAXyj0rF0odYBJyW8ysdD+6moyW02tcMbRnTV3OdRSYhNwQk1UgnjUu0j4saYuhXY3Z6Ete55KMSchNMF8h5epJP9+ZNKQVn9hTXcjVYhe4YRzz2VDY67DLFPI7lz2NPdWF8djcF7hhNFuyIXtN7MIFYLut+PF41Fvuuf8S7CRk+RJwcIFF2VDaJtbIbReqFVejrJl6qnOXktsDRwdiCeuyoXz48OHLly9GXvpwOHRvM5sjnBcuJXueZ75QOkgppbTxHvWiKB4fHz99+rT8jbR96/Va+021anahCoVuNpvdbmfDkcIJS7OhVP3qkotrmmamE7edVuV5jpIdFrKxbpPv+2rIcQ98399ut+g3LGRjNu6NuoZrei/glI3ZyLJMDfFd192iBjEYYmM21GRDfY1sgCk2ZiOKItO7AGDldSoAG1jXbzRNE8ex+lrdMGJ2f+BuWZeNqqrayYYQomkaXMMBI6zLhvpEzPReAGC+AXCGdf1GmqZZlrX/u91u7+czcrCKddlwXbd7G5V6ughgeTZmA3kAG2C+AcCzrt+I47h7UypuqQJT7MpG0zRFUZzcsI1sgBF2ZUMIsd/vTe8FABHmGzaI4zgMQ9N7Aafs6je6N1O11MIcRvZnbnme73a7qqpw67GF7MpG92aq7jcNXtVtF8/Vq6qq3W6X5/l2u23XrQKraM7Gyafao/38+fPVq1dq+bbpWxuuaZr3798TUZqm7TI52l8ijuM4jtWdY93tq0qFv3//9n1/+bSEYVgUhZEbEbIsS9PUdV2rxggrKaXGzRVFMT0bqojmy5cvn56egiBY7O+Vpqm6gvzmzZtv3765rhtFkd5shGGYpikRRVHUPQWrqorjOE3Th4eHp6enX79+GTlwz/OyLJvjwM8piiIMwzzPfd9XZ4468AVe+jrTC2QxHMfxfV8uuFZsv+qA9mJoqnAHnVnw82TNXyMHrg5z7ipwrX4pr+7S3fMtfzycddlQJ0r7rsxdsOJCKRmpaanzbrWqk7OtXaS9v5bh3IvkLnDgF1yooXV5x5ZkVzbKsmRPlDnKDAxfpH10K36hyuHARdrnaMWHN8/tgWssNHW18JXS79CWZ1c21Bz03E/b82n6GtLPXaR9RCt+dU3o4TnX2Io/t5yIxn77Qv95YW+HBGkmFmVDPe53daB5YRwy8FVG1+Mc2Iqfe0cnDpMmTkKmBGxivz2xSrDGIqbPYlE2XNf1PG/Ib3aHQ8P/XroGspdPMnUO9ZtGtcMTp9fjWnFdA7NxxXq0nNltupYsUWJLNpIkIaJnvXPtuf7u3bu/36pr6ftSCEkkhZC+L//3Fv748UPvBZBzrXgURSdv3rkrVKMNH5XNcUoNH5UNnFoMt9g1NMWKbNR1PWWM9DcbdS2FkEEg1V+tLGUQSCFUPD5//qy9rsXVMdKsE8qrrfh8Q5Gr3dfcB75MnUQrsqHexanH6fuyf/YHgfR9KeWfP38mbfw8thXvjt9mHQOwrfgyU1h2ErLYgc9xDe2E+WyUZUlEGo5QCNlvospSCjF1ywN0G7OF547dVjxJkoUvfXa7L4MHPsdnheaz4Xme67oaNnTuM/4FP/tvG7Pl65J1W/HlC2pOvHg4RXvg2tsCzfdTPZcqWaTnXtd//6XjkU5u0asq2myorqduHO6P4Wys12vXdfU867fbkRB08iBEGFLTUJJo2D7cGZPPb4Rh2DSNtsd6oojWayIi3yfHoaqiNKU0pbLUs324M8aeiW2aRj0joe1BBSGoLKlpaLOh1Yo2G2oaKkuy5nkAuC3GxlTqqbfj8WjPsywAXWbGVHmep2m63+8RDLCWmX5DldNGLQGwmYF+I01TNZpa/qUBhjMwFy+KIggCLAgNljP8+QaAtbCuIQAP2QDgIRsAPGQDgIdsAPCQDQAesgHAQzYAeMgGAA/ZAOAhGwA8ZAOAh2wA8JANAB6yAcBDNgB4yAYAD9kA4CEbADxkA4D3Xwhk8xGSAPJLAAAAAElFTkSuQmCC "Click for a 3D rendering of (6aR,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
TMA ((±)-3,4,5-Trimethoxy-α-methylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 22 3,4,5-Trimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
US: CSA Schedule I Section d Subsection 14 3,4,5-Trimethoxyamphetamine
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
Amfetamine (Amphetamine) ((±)-α-Methylphenethylamine)
[With thanks to Noel at NIH/NCGC for reporting an error in the chemical name given previously for this substance.]
CA: CDSA Schedule I Section 19 Subsection 1 Amphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 1 Amphetamine
UK: MDA Part II Class B Section 1(a) Amphetamine
US: CSA Schedule II Section d Subsection 1 Amphetamine
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: Amphetamine
Amineptine (7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)
CA: CDSA Schedule III Section 32 Amineptine
UK: MDA Part III Class C Section 1(a) Amineptine
2 C-B (4-Bromo-2,5-dimethoxyphenethylamine)
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
Dexamfetamine (Dexamphetamine) ((+)-α-Methylphenethylamine)
The CDSA does list Amphetamine but does not designate a specific optical isomer.
Dronabinol (delta-9-Tetrahydrocannabinol) ((6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol) and its stereochemical variants
CA: See Tetrahydrocannabinol, a more general designation which likely includes the delta-9 (Δ9) isomer specified here.
US: CSA Schedule III Section g Subsection 1 Dronabinol
Fenetylline (7-[2-[(α-Methylphenethyl)amino]ethyl]theophylline)
CA: CDSA Schedule III Section 20 Fenetylline
UK: MDA Part III Class C Section 1(a) Fenethylline
US: CSA Schedule I Section f Subsection 4 Fenethylline
Effective 13 Mar 2013, CND 56/1 added:
GHB (γ-Hydroxybutyric acid)
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
UN: Previously at Psychotropics Schedule IV GHB
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Mecloqualone (3-(o-Chlorophenyl)-2-methyl-4(3H)-quinazolinone)
CA: CDSA Schedule III Section 4 Mecloqualone
UK: MDA Part II Class B Section 1(a) Mecloqualone
US: CSA Schedule I Section e Subsection 2 Mecloqualone
Metamfetamine racemate (Methamphetamine racemate) ((±)-N,α-Dimethylphenethylamine)
CA: CDSA Schedule I Section 18 Methamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 23 Methamphetamine
UK: MDA Part I Class A Section 1(a) Methylamphetamine
US: CSA Schedule II Section d Subsection 2 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
Methaqualone (2-Methyl-3-o-tolyl-4(3H)-quinazolinone)
CA: CDSA Schedule III Section 3 Methaqualone
UK: MDA Part II Class B Section 1(a) Methaqualone
US: CSA Schedule I Section e Subsection 3 Methaqualone
⇒
PubChem: 6292; ChemSpider: 6055; Bluelight: Methaqualone; Drugs Forum: Methaqualone; Erowid: Methaqualone; Wikipedia: Methaqualone
Methylphenidate (Methyl α-phenyl-2-piperidine acetate)
CA: CDSA Schedule III Section 2 Methylphenidate
UK: MDA Part II Class B Section 1(a) Methylphenidate
US: CSA Schedule II Section d Subsection 4 Methylphenidate
⇒
PubChem: 4158; ChemSpider: 4015; Bluelight: Methylphenidate; Drugs Forum: Methylphenidate; Erowid: Methylphenidate; Wikipedia: Methylphenidate
Phencyclidine (PCP) (1-(1-Phenylcyclohexyl)piperidine)
CA: CDSA Schedule I Section 14 Phencyclidine
UK: MDA Part I Class A Section 1(a) Phencyclidine
US: CSA Schedule II Section e Subsection 4 Phencyclidine
⇒
PubChem: 6468; ChemSpider: 6224; Bluelight: PCP; Drugs Forum: Phencyclidine; Erowid: PCP; Wikipedia: Phencyclidine
Phenmetrazine (3-Methyl-2-phenylmorpholine)
CA: CDSA Schedule IV Section 6 Phenmetrazine
UK: MDA Part II Class B Section 1(a) Phenmetrazine
US: CSA Schedule II Section d Subsection 3 Phenmetrazine
Secobarbital (5-Allyl-5-(1-methylbutyl)barbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 24 Secobarbital
US: CSA Schedule II Section e Subsection 5 Secobarbital, Schedule III Section c Subsection 1 Item ii Secobarbital and Subsection 2 Item ii Secobarbital
⇒
PubChem: 5193; ChemSpider: 5005; Bluelight: Secobarbital bioavailability; Drugs Forum: Secobarbital; Erowid: Barbiturates; Wikipedia: Secobarbital
Amobarbital (5-Ethyl-5-isopentylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 3 Amobarbital
US: CSA Schedule II Section e Subsection 1 Amobarbital, Schedule III Section c Subsection 1 Item i Amobarbital and Subsection 2 Item i Amobarbital
Buprenorphine (21-Cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine)
CA: CDSA Schedule I Section 10 Subsection 1 Buprenorphine
UK: MDA Part III Class C Section 1(a) Buprenorphine
US: CSA Schedule III Section e Subsection 2 Item i Buprenorphine
⇒
PubChem: 40400 644073; ChemSpider: 559124; Bluelight: Buprenorphine; Drugs Forum: Buprenorphine; Erowid: Buprenorphine; Wikipedia: Buprenorphine
Butalbital (5-Allyl-5-isobutylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 8 Butalbital
Cyclobarbital (5-(1-Cyclohexen-1-yl)-5-ethylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 11 Cyclobarbital
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule I Section 20 Flunitrazepam
CA: [revoked] CDSA Schedule III Section 25 Flunitrazepam
UK: MDA Part III Class C Section 1(a) Flunitrazepam
US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
⇒
PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
Glutethimide (2-Ethyl-2-phenylglutarimide)
CA: CDSA Schedule IV Section 11 Glutethimide
UK: MDA Part II Class B Section 1(a) Glutethimide
US: CSA Schedule II Section e Subsection 2 Glutethimide
Metazocine (2ʹ-Hydroxy-2,5,9-trimethyl-6,7-benzomorphan)
CA: CDSA Schedule I Section 11 Subsection 2 Metazocine
UK: MDA Part I Class A Section 1(a) Metazocine and Part II Class B Section 1(a) Metazocine
US: CSA Schedule II Section c Subsection 14 Metazocine
See also Narcotics Part 1 Section 1 Metazocine
Pentobarbital (5-Ethyl-5-(1-methylbutyl)barbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 20 Pentobarbital
US: CSA Schedule II Section e Subsection 3 Pentobarbital, Schedule III Section c Subsection 1 Item iii Pentobarbital and Subsection 2 Item iii Pentobarbital
⇒
PubChem: 4737; ChemSpider: 4575; Bluelight: Pentobarbital; Drugs Forum: Pentobarbital; Erowid: Barbiturates; Wikipedia: Pentobarbital
Allobarbital (5,5-Diallylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 1 Allobarbital
Alprazolam (8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine)
CA: CDSA Schedule IV Section 18 Subsection 1 Alprazolam
UK: MDA Part III Class C Section 1(a) Alprazolam
US: CSA Schedule IV Section c Subsection 2 Alprazolam
⇒
PubChem: 2118; ChemSpider: 2034; Bluelight: Alprazolam; Drugs Forum: Alprazolam; Erowid: Alprazolam; Wikipedia: Alprazolam
Amfepramone (Diethylpropion) (2-(Diethylamino)propiophenone)
CA: CDSA Schedule IV Section 4 Diethylpropion
UK: MDA Part II Class B Section 1(aa) Diethylpropion and Part III Class C Section 1(a) Diethylpropion
US: CSA Schedule IV Section f Subsection 2 Diethylpropion
Benzfetamine (Benzphetamine) (N-Benzyl-N,α-dimethylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 17 Benzphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 18 Benzphetamine
UK: MDA Part III Class C Section 1(a) Benzphetamine
US: CSA Schedule III Section b Subsection 2 Benzphetamine
Bromazepam (7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 2 Bromazepam
UK: MDA Part III Class C Section 1(a) Bromazepam
US: CSA Schedule IV Section c Subsection 4 Bromazepam
⇒
PubChem: 2441; ChemSpider: 2347; Drugs Forum: Bromazepam; Erowid: Bromazepam; Wikipedia: Bromazepam
Brotizolam (2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)
CA: CDSA Schedule IV Section 18 Subsection 2.1 Brotizolam
UK: MDA Part III Class C Section 1(a) Brotizolam
Butobarbital (5-Butyl-5-ethylbarbituricacid)
CA: CDSA Schedule IV Section 1 Subsection 10 Butethal
Chlordiazepoxide (7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide)
CA: CDSA Schedule IV Section 18 Subsection 4 Chlordiazepoxide
UK: MDA Part III Class C Section 1(a) Chlordiazepoxide
US: CSA Schedule IV Section c Subsection 9 Chlordiazepoxide
⇒
PubChem: 2712; ChemSpider: 10248513; Drugs Forum: Chlordiazepoxide; Erowid: Chlordiazepoxide; Wikipedia: Chlordiazepoxide
Clonazepam (5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 6 Clonazepam
UK: MDA Part III Class C Section 1(a) Clonazepam
US: CSA Schedule IV Section c Subsection 11 Clonazepam
⇒
PubChem: 2802; ChemSpider: 2700; Bluelight: Clonazepam; Drugs Forum: Clonazepam; Erowid: Clonazepam; Wikipedia: Clonazepam
Clorazepate (7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid)
CA: CDSA Schedule IV Section 18 Subsection 7 Clorazepate
UK: MDA Part III Class C Section 1(a) Clorazepic acid
US: CSA Schedule IV Section c Subsection 12 Clorazepate
Clotiazepam (5-(o-Chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one)
CA: CDSA Schedule IV Section 12 Clotiazepam
UK: MDA Part III Class C Section 1(a) Clotiazepam
US: CSA Schedule IV Section c Subsection 13 Clotiazepam
Cloxazolam (10-Chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one)
CA: CDSA Schedule IV Section 18 Subsection 8 Cloxazolam
UK: MDA Part III Class C Section 1(a) Cloxazolam
US: CSA Schedule IV Section c Subsection 14 Cloxazolam
Delorazepam (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 9 Delorazepam
UK: MDA Part III Class C Section 1(a) Delorazepam
US: CSA Schedule IV Section c Subsection 15 Delorazepam
Ethchlorvynol (1-Chloro-3-ethyl-1-penten-4-yn-3-ol)
CA: CDSA Schedule IV Section 13 Ethchlorvynol
UK: MDA Part III Class C Section 1(a) Ethchlorvynol
US: CSA Schedule IV Section c Subsection 19 Ethchlorvynol
Ethinamate (1-Ethynylcyclohexanolcarbamate)
CA: CDSA Schedule IV Section 14 Ethinamate
UK: MDA Part III Class C Section 1(a) Ethinamate
US: CSA Schedule IV Section c Subsection 20 Ethinamate
Ethyl loflazepate (Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate)
CA: CDSA Schedule IV Section 18 Subsection 12 Ethyl loflazepate
UK: MDA Part III Class C Section 1(a) Ethyl loflazepate
US: CSA Schedule IV Section c Subsection 21 Ethyl loflazepate
Etilamfetamine (N-Ethylamphetamine) (N-Ethyl-α-methylphenethylamine)
CA: CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
Fencamfamin (N-Ethyl-3-phenyl-2-norbornanamine)
CA: CDSA Schedule IV Section 20 Fencamfamin
UK: MDA Part III Class C Section 1(a) Fencamfamin
US: CSA Schedule IV Section f Subsection 3 Fencamfamin
Fenproporex ((±)-3-[(α-Methylphenylethyl)amino]propionitrile)
CA: CDSA Schedule IV Section 21 Fenproporex
UK: MDA Part III Class C Section 1(a) Fenproporex
US: CSA Schedule IV Section f Subsection 4 Fenproporex
Fludiazepam (7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 13 Fludiazepam
UK: MDA Part III Class C Section 1(a) Fludiazepam
US: CSA Schedule IV Section c Subsection 22 Fludiazepam
Flurazepam (7-Chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 15 Flurazepam
UK: MDA Part III Class C Section 1(a) Flurazepam
US: CSA Schedule IV Section c Subsection 24 Flurazepam
Effective 13 Mar 2013, CND 56/1 revoked:
GHB (γ-Hydroxybutyric acid)
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
UN: Currently at Psychotropics Schedule II GHB
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Haloxazolam (10-Bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one)
CA: CDSA Schedule IV Section 18 Subsection 17 Haloxazolam
UK: MDA Part III Class C Section 1(a) Haloxazolam
US: CSA Schedule IV Section c Subsection 27 Haloxazolam
Lefetamine (SPA) ((–)-N,N-Dimethyl-1,2-diphenylethylamine)
CA: CDSA Schedule III Section 29 Lefetamine
UK: MDA Part II Class B Section 1(a) Lefetamine
US: CSA Schedule IV Section f Subsection 12 SPA
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine
Loprazolam (6-(o-Chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepine-1-one)
[With thanks to Zuo Ning for pointing out the previous entries for Loprazolam and Lorazepam were badly tangled up.]
CA: CDSA Schedule IV Section 18 Subsection 19 Loprazolam
UK: MDA Part III Class C Section 1(a) Loprazolam
US: CSA Schedule IV Section c Subsection 29 Loprazolam
Lormetazepam (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 21 Lormetazepam
UK: MDA Part III Class C Section 1(a) Lormetazepam
US: CSA Schedule IV Section c Subsection 31 Lormetazepam
Meprobamate (2-Methyl-2-propyl-1,3-propanedioldicarbamate)
CA: CDSA Schedule IV Section 16 Meprobamate
UK: MDA Part III Class C Section 1(a) Meprobamate
US: CSA Schedule IV Section c Subsection 34 Meprobamate
Methylphenobarbital (5-Ethyl-1-methyl-5-phenylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 18 Methylphenobarbital
UK: MDA Part II Class B Section 1(a) Methylphenobarbitone
Methyprylon (3,3-Diethyl-5-methyl-2,4-piperidinedione)
CA: CDSA Schedule IV Section 17 Methyprylon
UK: MDA Part III Class C Section 1(a) Methyprylone
US: CSA Schedule III Section c Subsection 10 Methyprylon
Nimetazepam (1,3-Dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 23 Nimetazepam
UK: MDA Part III Class C Section 1(a) Nimetazepam
US: CSA Schedule IV Section c Subsection 38 Nimetazepam
⇒
PubChem: 4496; ChemSpider: 4340; Drugs Forum: Nimetazepam; Erowid: Nimetazepam; Wikipedia: Nimetazepam
Nitrazepam (1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 24 Nitrazepam
UK: MDA Part III Class C Section 1(a) Nitrazepam
US: CSA Schedule IV Section c Subsection 39 Nitrazepam
⇒
PubChem: 4506; ChemSpider: 4350; Drugs Forum: Nitrazepam; Erowid: Nitrazepam Synthesis; Wikipedia: Nitrazepam
Nordazepam (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 25 Nordazepam
UK: MDA Part III Class C Section 1(a) Nordazepam
US: CSA Schedule IV Section c Subsection 40 Nordiazepam
⇒
PubChem: 2997; ChemSpider: 2890; Bluelight: Nordiazepam ; Erowid: Nordiazepam Synthesis; Wikipedia: Nordazepam
Phendimetrazine ((+)-(2S,3S)-3,4-Dimethyl-2-phenylmorpholine)
CA: CDSA Schedule IV Section 5 Phendimetrazine
UK: MDA Part III Class C Section 1(a) Phendimetrazine
US: CSA Schedule III Section b Subsection 5 Phendimetrazine
Phenobarbital (5-Ethyl-5-phenylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 21 Phenobarbital
US: CSA Schedule IV Section c Subsection 45 Phenobarbital
⇒
PubChem: 4763; ChemSpider: 4599; Bluelight: Phenobarbital vs. benzo's; Drugs Forum: Phenobarbital; Erowid: Barbiturates; Wikipedia: Phenobarbital
Phentermine (α,α-Dimethylphenethylamine)
CA: CDSA Schedule IV Section 8 Phentermine
UK: MDA Part III Class C Section 1(a) Phentermine
US: CSA Schedule IV Section f Subsection 9 Phentermine
Pyrovalerone (4ʹ-Methyl-2-(1-pyrrolidinyl)valerophenone)
CA: CDSA Schedule IV Section 26 Pyrovalerone
UK: MDA Part II Class B Section 1(aa) Pyrovalerone and Part III Class C Section 1(a) Pyrovalerone
US: CSA Schedule V Section d Subsection 1 Pyrovalerone
Secbutabarbital (5-sec-Butyl-5-ethylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 7 Butabarbital
Tetrazepam (7-Chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
CA: CDSA Schedule IV Section 18 Subsection 31 Tetrazepam
UK: MDA Part III Class C Section 1(a) Tetrazepam
US: CSA Schedule IV Section c Subsection 51 Tetrazepam
⇒
PubChem: 25215; ChemSpider: 23551; Bluelight: Tetrazepam; Drugs Forum: Tetrazepam; Wikipedia: Tetrazepam
Vinylbital (5-(1-Methylbutyl)-5-vinylbarbituric acid)
CA: CDSA Schedule IV Section 1 Subsection 28 Vinylbital
Precursors and Chemicals Frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances under International Control (“Red List”)
Source: International Narcotics Control Board. Precursors and Chemicals frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances under International Control—The Red List, 13th Edition, January 2012
Acetic anhydride (Acetic oxide)
CA: CDSA Schedule VI Part 1 Subsection 1 Acetic anhydride
EU: Drug precursors Annex I Category 2 Acetic anhydride and Annex II Acetic anhydride
UK: MDA Drug precursors Annex I Category 2 Acetic anhydride and Drug precursors Annex II Acetic anhydride
US: CSA Listed Chemicals Section b Subsection 1 Acetic anhydride
N-Acetylanthranilic acid (2-(Acetylamino)benzoic acid)
CA: CDSA Schedule VI Part 1 Subsection 2 N-Acetylanthranilic acid
EU: Drug precursors Annex I Category 1 N-Acetylanthranilic acid
UK: MDA Drug precursors Annex I Category 1 N-Acetylanthranilic acid
US: CSA Listed Chemicals Section a Subsection 6 N-Acetylanthranilic acid
Ergometrine ([8β(S)]-9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide)
CA: CDSA Schedule VI Part 1 Subsection 5 Ergometrine
EU: Drug precursors Annex I Category 1 Ergometrine
UK: MDA Drug precursors Annex I Category 1 Ergometrine
US: CSA Listed Chemicals Section a Subsection 4 Ergonovine
Ergotamine (12ʹ-Hydroxy-2ʹ-methyl-5ʹ-(phenylmethyl)ergotaman-3ʹ,6ʹ,18ʹ-trione)
CA: CDSA Schedule VI Part 1 Subsection 6 Ergotamine
EU: Drug precursors Annex I Category 1 Ergotamine
UK: MDA Drug precursors Annex I Category 1 Ergotamine
US: CSA Listed Chemicals Section a Subsection 5 Ergotamine
Isosafrole (5-(1-Propenyl)-1,3-benzodioxole)
CA: CDSA Schedule VI Part 1 Subsection 7 Isosafrole
EU: Drug precursors Annex I Category 1 Isosafrole
UK: MDA Drug precursors Annex I Category 1 Isosafrole
US: CSA Listed Chemicals Section a Subsection 16 Isosafrole
Lysergic acid ((8β)-9,10-Didehydro-6-methylergoline-8-carboxylic acid)
CA: CDSA Schedule VI Part 1 Subsection 8 Lysergic acid
EU: Drug precursors Annex I Category 1 Lysergic acid
UK: MDA Drug precursors Annex I Category 1 Lysergic acid
US: CSA Schedule III Section c Subsection 8 Lysergic acid
3,4-Methylenedioxyphenyl-2-propanone (1-[3,4-(Methylenedioxy)phenyl]-2-propanone)
CA: CDSA Schedule VI Part 1 Subsection 9 3,4-Methylenedioxyphenyl-2-propanone
EU: Drug precursors Annex I Category 1 3,4-Methylenedioxyphenylpropan-2-one
UK: MDA Drug precursors Annex I Category 1 3,4-Methylenedioxyphenyl-2-propanone
US: CSA Listed Chemicals Section a Subsection 12 3,4-Methylenedioxyphenyl-2-propanone
Norephedrine ((R*,S*)-α-(1-Aminoethyl)benzenemethanol)
CA: CDSA Schedule VI Part 1 Subsection 10 Norephedrine
EU: Drug precursors Annex I Category 1 Norephedrine
UK: MDA Drug precursors Annex I Category 1 Norephedrine
US: CSA Listed Chemicals Section a Subsection 9 Phenylpropanolamine
⇒
PubChem: 10297 26934; ChemSpider: 9875; Bluelight: Phenylpropanolamine; Erowid: Phenylpropanolamine; Wikipedia: Phenylpropanolamine
1-Phenyl-2-propanone (1-Phenyl-2-propanone)
CA: CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UK: MDA Drug precursors Annex I Category 1 1-Phenyl-2-propanone
US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
Potassium permanganate (Permanganic acid (HMnO4), potassium salt)
CA: CDSA Schedule VI Part 1 Subsection 15 Potassium permanganate
EU: Drug precursors Annex I Category 2 Potassium permanganate and Annex II Potassium permanganate
UK: MDA Drug precursors Annex I Category 2 Potassium permanganate and Drug precursors Annex II Potassium permanganate
US: CSA Listed Chemicals Section b Subsection 5 Potassium permanganate
⇒
PubChem: 516875; ChemSpider: 22810; Bluelight: KMnO4 substitute; Wikipedia: Potassium permanganate
Pseudoephedrine ([S-(R*,R*)]-α-[1-(Methylamino)ethyl]benzenemethanol)
CA: CDSA Schedule VI Part 1 Subsection 16 Pseudoephedrine
EU: Drug precursors Annex I Category 1 Pseudoephedrine
UK: MDA Drug precursors Annex I Category 1 Pseudoephedrine
US: CSA Listed Chemicals Section a Subsection 11 Pseudoephedrine
⇒
PubChem: 7028; ChemSpider: 6761; Bluelight: Pseudoephedrine; Drugs Forum: Pseudoephedrine; Erowid: Ephedrine; Wikipedia: Pseudoephedrine
Safrole (5-(2-Propenyl)-1,3-benzodioxole)
CA: CDSA Schedule VI Part 1 Subsection 17 Safrole
EU: Drug precursors Annex I Category 1 Safrole
UK: MDA Drug precursors Annex I Category 1 Safrole
US: CSA Listed Chemicals Section a Subsection 17 Safrole
⇒
PubChem: 5144; ChemSpider: 13848731; Bluelight: Safrole; Erowid: Safrole Synthesis; Wikipedia: SafroleTable II
Each Table II substance [with the exception of Hydrochloric acid and Sulphuric acid] includes the salts of that substance whenever such salts are possible.
Anthranilic acid (2-Aminobenzoic acid)
CA: CDSA Schedule VI Part 1 Subsection 3 Anthranilic acid
EU: Drug precursors Annex I Category 2 Anthranilic acid and Annex II Anthranilic acid
UK: MDA Drug precursors Annex I Category 2 Anthranilic acid and Drug precursors Annex II Anthranilic acid
US: CSA Listed Chemicals Section a Subsection 1 Anthranilic acid
Ethyl ether (1,1ʹ-Oxybis[ethane])
CA: CDSA Schedule VI Part 2 Subsection 2 Ethyl ether
EU: Drug precursors Annex I Category 3 Ethyl ether
UK: MDA Drug precursors Annex I Category 3 Ethyl ether
US: CSA Listed Chemicals Section b Subsection 4 Ethyl ether
Hydrochloric acid
The salts of Hydrochloric acid are specifically excluded.
CA: CDSA Schedule VI Part 2 Subsection 3 Hydrochloric acid
EU: Drug precursors Annex I Category 3 Hydrochloric acid
UK: MDA Drug precursors Annex I Category 3 Hydrochloric acid
US: CSA Listed Chemicals Section b Subsection 8 Hydrochloric acid
Methyl ethyl ketone (2-Butanone)
CA: CDSA Schedule VI Part 2 Subsection 4 Methyl ethyl ketone
EU: Drug precursors Annex I Category 3 Methylethylketone
UK: MDA Drug precursors Annex I Category 3 Methyl ethyl ketone
US: CSA Listed Chemicals Section b Subsection 6 2-Butanone
Phenylacetic acid (Benzeneacetic acid)
CA: CDSA Schedule VI Part 1 Subsection 12 Phenylacetic acid
EU: Drug precursors Annex I Category 2 Phenylacetic acid and Annex II Phenylacetic acid
UK: MDA Drug precursors Annex I Category 2 Phenylacetic acid and Drug precursors Annex II Phenylacetic acid
US: CSA Listed Chemicals Section a Subsection 8 Phenylacetic acid
⇒
PubChem: 999; ChemSpider: 10181341; Erowid: Phenylacetic acid synthesis; Wikipedia: Phenylacetic acid
Piperidine
CA: CDSA Schedule VI Part 1 Subsection 13 Piperidine
EU: Drug precursors Annex I Category 2 Piperidine and Annex II Piperidine
UK: MDA Drug precursors Annex I Category 2 Piperidine and Drug precursors Annex II Piperidine
US: CSA Listed Chemicals Section a Subsection 10 Piperidine
⇒
PubChem: 8082; ChemSpider: 7791; Drugs Forum: Piperidines; Erowid: Piperidine; Wikipedia: Piperidine
Sulphuric acid (Sulfuric acid)
The salts of Sulphuric acid are specifically excluded.
CA: CDSA Schedule VI Part 2 Subsection 5 Sulphuric acid
EU: Drug precursors Annex I Category 3 Sulphuric acid
UK: MDA Drug precursors Annex I Category 3 Sulphuric acid
US: CSA Listed Chemicals Section b Subsection 9 Sulfuric acid
11 March 2016 · 
· Isomer Design
· Isomer Design